CA - Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript
2024-03-07 23:35:04 ET
Profound Medical Corp. (PROF)
Q4 2023 Earnings Conference Call
March 07, 2024 4:30 PM ET
Company Participants
Stephen Kilmer – Investor Relations
Arun Menawat – Chief Executive Officer
Rashed Dewan – Chief Financial Officer
Mathieu Burtnyk – Chief Operating Officer
Conference Call Participants
Rick Wise – Stifel
Rahul Sarugaser – Raymond James
Michael Sarcone – Jefferies
Brian Gagnon – Gagnon Securities
Chris Potter – Northern Border Investments
Presentation
Operator
Good day, and welcome to the Profound Medical Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Stephen Kilmer, Investor Relations. Please go ahead.
Stephen Kilmer
Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable Securities Laws of the United States and Canada. All forward-looking statements are based on Profound's current beliefs, assumptions, and expectations and relate to, among other things, expectations regarding the efficacy of the company's treatment technologies, results of future clinical trials, the ability to obtain coding and/or reimbursement from third-party payers, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance, and future commitments. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements.
No forward-looking statement can be guaranteed. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. Profound undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required by law.
Representing the company today are Dr. Arun Menawat, Profound's Chief Executive Officer; Rashed Dewan, the company’s Chief Financial Officer; and Dr. Mathieu Burtnyk, Profound's Chief Operating Officer....
Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript